Guard Medical Inc., a Miami, Florida-based developer of options that allow prophylactic Unfavorable Strain Wound Remedy (NPWT) wound care of closed surgical incisions, closed an $11m Collection B funding spherical.
Present buyers embrace Bpifrance and Matignon Investissement et Gestion.
Led by Machiel van der Leest, CEO, Guard Medical is growing options that allow prophylactic Unfavorable Strain Wound Remedy (NPWT) to be used on a variety of surgical wound varieties and sizes with broad purposes for an infection prevention, scar mitigation and enhanced cosmesis. Its NPWT expertise originated with NewYork-Presbyterian and Weill Cornell Medication in response to doctor’s identification of unmet wants associated to Surgical Website Infections (SSI).
The capital will help commercialization and scientific research of its (NPWT) dressing NPsealTM for the remedy of closed surgical incisions. NPsealTM is an easy-to-use and cost-effective NPWT surgical dressing with an built-in pump that establishes and maintains destructive strain with just some pinches.